TR201712424A2 - Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ - Google Patents

Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ Download PDF

Info

Publication number
TR201712424A2
TR201712424A2 TR2017/12424A TR201712424A TR201712424A2 TR 201712424 A2 TR201712424 A2 TR 201712424A2 TR 2017/12424 A TR2017/12424 A TR 2017/12424A TR 201712424 A TR201712424 A TR 201712424A TR 201712424 A2 TR201712424 A2 TR 201712424A2
Authority
TR
Turkey
Prior art keywords
dry powder
powder inhalation
inhalation compositions
compositions
copd
Prior art date
Application number
TR2017/12424A
Other languages
English (en)
Inventor
Çeli̇k Devri̇m
Türkyilmaz Ali̇
Original Assignee
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/12424A priority Critical patent/TR201712424A2/tr
Priority to PCT/TR2018/050437 priority patent/WO2019098969A2/en
Priority to EP18869456.6A priority patent/EP3672574A2/en
Publication of TR201712424A2 publication Critical patent/TR201712424A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, kuru toz farmasötik bileşimler ve bu bileşimlerin kronik obstrüktif akciğer hastalığı (KOAH), astım ve diğer obstrüktif solunum yolu hastalıklarının tedavisinde inhalerler vasıtasıyla uygulanması ile ilgilidir.
TR2017/12424A 2017-08-21 2017-08-21 Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ TR201712424A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/12424A TR201712424A2 (tr) 2017-08-21 2017-08-21 Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
PCT/TR2018/050437 WO2019098969A2 (en) 2017-08-21 2018-08-17 Dry powder compositions for inhalation
EP18869456.6A EP3672574A2 (en) 2017-08-21 2018-08-17 Dry powder compositions for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/12424A TR201712424A2 (tr) 2017-08-21 2017-08-21 Kuru toz i̇nhalasyon bi̇leşi̇mleri̇

Publications (1)

Publication Number Publication Date
TR201712424A2 true TR201712424A2 (tr) 2019-03-21

Family

ID=66218398

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/12424A TR201712424A2 (tr) 2017-08-21 2017-08-21 Kuru toz i̇nhalasyon bi̇leşi̇mleri̇

Country Status (3)

Country Link
EP (1) EP3672574A2 (tr)
TR (1) TR201712424A2 (tr)
WO (1) WO2019098969A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022045995A1 (en) * 2020-08-28 2022-03-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004019985A1 (en) * 2002-08-29 2004-03-11 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
EP1894568A1 (en) * 2006-08-31 2008-03-05 Novartis AG Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
TR201000623A2 (tr) * 2010-01-28 2011-08-22 B�Lg�� Mahmut Yeni tiotropyum kombinasyonu.
TR201000680A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
KR20180028563A (ko) * 2010-10-12 2018-03-16 시플라 리미티드 약학 조성물
MX2013014399A (es) * 2011-06-08 2014-03-21 Glaxo Group Ltd Combinacion que comprende umeclidinio y un corticosteroide.
CN104470503A (zh) * 2012-04-13 2015-03-25 葛兰素史克知识产权开发有限公司 聚集粒子
WO2014007770A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
US20150174064A1 (en) * 2012-07-05 2015-06-25 Arven IIac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and glucose anhydrous
WO2014007767A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
UA115989C2 (uk) * 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
US10111957B2 (en) * 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
EP3148521B1 (en) * 2014-05-28 2019-12-18 GlaxoSmithKline Intellectual Property Development Limited Fluticasone furoate in the treatment of copd

Also Published As

Publication number Publication date
WO2019098969A2 (en) 2019-05-23
EP3672574A2 (en) 2020-07-01
WO2019098969A3 (en) 2019-08-08

Similar Documents

Publication Publication Date Title
CY1123478T1 (el) Μεθοδοι αγωγης αυτοανοσων, αναπνευστικων και φλεγμονωδων διαταραχων δια εισπνοης ν-οξειδιου της ροφλουμιλαστης
CY1120605T1 (el) Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης
EA201591729A1 (ru) Пригодные для вдыхания агломераты частиц пористого носителя и тонкоизмельченного лекарственного средства
EA201201397A1 (ru) Ингалятор, содержащий расслаиваемую блистерную упаковку
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
BR112017023351A2 (pt) composições multidrogas de matriz frágil
PH12017502087B1 (en) Tiotropium inhalation solution for nebulization
MX375632B (es) Inhalador de polvo de dosis individual y procedimiento para su fabricación.
EA201201392A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
EA201201395A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
MX373699B (es) Composicion farmaceutica que contiene budesonida y formoterol.
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
EA201201389A1 (ru) Ингалятор, создающий турбулентность
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
TR201712424A2 (tr) Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
TR201916307A1 (tr) İnhalasyon i̇çi̇n kuru toz kompozi̇syonlarinin hazirlanmasina yöneli̇k bi̇r i̇şlem
MX372705B (es) Composición farmacéutica que contiene budesonida y formoterol
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
TR2023007360T2 (tr) A process for the preparation of dry powder compositions for inhalation
TR201716209A2 (tr) Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.
TR201620103A2 (tr) İnhalasyon i̇le uygulanan formülasyonlar
TR201716199A1 (tr) Arformoterol ve ipratropium içeren yeni farmasötik bileşimler.